The ability to take a promising idea to build phase is a long and winding path. Building an operational framework that is scalable and flexible enough for modern biotechs is what allows for hypergrowth. Join this panel of top-tier VCs as they provide insight, trends, and lessons learned for launching successful early-stage companies.